Study: TAVR lowers mortality in high-risk diabetes patients

09/10/2013 | Healio

Transcatheter aortic valve replacement was associated with improved survival in high-risk patients with diabetes and aortic stenosis, according to new research. Mortality at one year was 18% in patients treated with TAVR, compared with 27.4% in those who had surgical aortic valve replacement. The results were presented at the European Society of Cardiology Congress.

View Full Article in:

Healio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC